Showing results (91-100 of 315) with videos related to
Sort By:
Pageof 32
Nature Chemical Biology|November 14, 2017
Nonimmune cells equipped with T-cell-receptor-like signaling for cancer cell ablationRyosuke Kojima, Leo Scheller, Martin FusseneggerSynthetic Biology (Oxford, England)|April 5, 2021
Engineering precision therapies: lessons and motivations from the clinicMingqi Xie, Mirta Viviani, Martin FusseneggerMethods in Molecular Biology (Clifton, N.J.)|August 13, 2017
Design of Synthetic Promoters for Gene Circuits in Mammalian CellsPratik Saxena, Daniel Bojar, Martin FusseneggerCurrent Opinion in Biotechnology|May 3, 2016
Synthetic biology-application-oriented cell engineeringMingqi Xie, Viktor Haellman, Martin FusseneggerMetabolic Engineering|November 24, 2018
Purity by design: Reducing impurities in bioproduction by stimulus-controlled global translational downregulation of non-product proteinsDaniel Bojar, Tobias Fuhrer, Martin FusseneggerMetabolic Engineering|August 17, 2005
Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particlesBarbara Mitta, Markus Rimann, Martin FusseneggerMetabolic Engineering|November 27, 2012
Increasing the dynamic control space of mammalian transcription devices by combinatorial assembly of homologous regulatory elements from different bacterial speciesWilliam Bacchus, Wilfried Weber, Martin FusseneggerAdvanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 16, 2019
Light-Controlled Mammalian Cells and Their Therapeutic Applications in Synthetic BiologyMaysam Mansouri, Tobias Strittmatter, Martin FusseneggerProceedings of the National Academy of Sciences of the United States of America|March 30, 2019
A CRISPR/Cas9-based central processing unit to program complex logic computation in human cellsHyojin Kim, Daniel Bojar, Martin FusseneggerThe Journal of Gene Medicine|September 24, 2004
Dual-regulated myoD- and msx1-based interventions in C2C12-derived cells enable precise myogenic/osteogenic/adipogenic lineage controlCornelia Fux, Dominik Langer, Martin FusseneggerPageof 32